These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
79 related articles for article (PubMed ID: 2391394)
1. Thermal injury effects on drug disposition: a prospective study with piperacillin. Shikuma LR; Ackerman BH; Weaver RH; Solem LD; Strate RG; Cerra FB; Zaske DE J Clin Pharmacol; 1990 Jul; 30(7):632-7. PubMed ID: 2391394 [TBL] [Abstract][Full Text] [Related]
2. Effects of treatment and the metabolic response to injury on drug clearance: a prospective study with piperacillin. Shikuma LR; Ackerman BH; Weaver RH; Solem LD; Strate RG; Cerra FB; Zaske DE Crit Care Med; 1990 Jan; 18(1):37-41. PubMed ID: 2293966 [TBL] [Abstract][Full Text] [Related]
3. Population Pharmacokinetics of Piperacillin in Nonobese, Obese, and Morbidly Obese Critically Ill Patients. Alobaid AS; Wallis SC; Jarrett P; Starr T; Stuart J; Lassig-Smith M; Mejia JL; Roberts MS; Roger C; Udy AA; Lipman J; Roberts JA Antimicrob Agents Chemother; 2017 Mar; 61(3):. PubMed ID: 28052849 [TBL] [Abstract][Full Text] [Related]
4. Piperacillin-tazobactam pharmacokinetics in patients with intraabdominal infections. Jhee SS; Kern JW; Burm JP; Yellin AE; Gill MA Pharmacotherapy; 1995; 15(4):472-8. PubMed ID: 7479200 [TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetic analysis of piperacillin administered with tazobactam in critically ill, morbidly obese surgical patients. Sturm AW; Allen N; Rafferty KD; Fish DN; Toschlog E; Newell M; Waibel B Pharmacotherapy; 2014 Jan; 34(1):28-35. PubMed ID: 23864417 [TBL] [Abstract][Full Text] [Related]
6. Piperacillin pharmacokinetics in pediatric patients. Wilson CB; Koup JR; Opheim KE; Adelman LA; Levy J; Stull TL; Clausen C; Smith AL Antimicrob Agents Chemother; 1982 Sep; 22(3):442-7. PubMed ID: 6215893 [TBL] [Abstract][Full Text] [Related]
7. [Retrospective cohort study on the correlation between high value of lactic acid and risk of death in 127 patients with extensive burn during shock stage]. Ding XB; Chen J; Yang YT; Peng X; Yan H; Peng YZ Zhonghua Shao Shang Za Zhi; 2019 May; 35(5):326-332. PubMed ID: 31154729 [No Abstract] [Full Text] [Related]
8. Disposition kinetics and bioavailability of piperacillin and cephapirin in mares. el-Komy AA Dtsch Tierarztl Wochenschr; 1995 Jun; 102(6):244-8. PubMed ID: 8582260 [TBL] [Abstract][Full Text] [Related]
9. The impact of variation in renal replacement therapy settings on piperacillin, meropenem, and vancomycin drug clearance in the critically ill: an analysis of published literature and dosing regimens*. Jamal JA; Udy AA; Lipman J; Roberts JA Crit Care Med; 2014 Jul; 42(7):1640-50. PubMed ID: 24674926 [TBL] [Abstract][Full Text] [Related]
10. Population pharmacokinetics and pharmacodynamics of piperacillin/tazobactam in patients with complicated intra-abdominal infection. Li C; Kuti JL; Nightingale CH; Mansfield DL; Dana A; Nicolau DP J Antimicrob Chemother; 2005 Aug; 56(2):388-95. PubMed ID: 16002420 [TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics of piperacillin and tazobactam in plasma and subcutaneous interstitial fluid in critically ill patients receiving continuous venovenous haemodiafiltration. Varghese JM; Jarrett P; Boots RJ; Kirkpatrick CM; Lipman J; Roberts JA Int J Antimicrob Agents; 2014 Apr; 43(4):343-8. PubMed ID: 24612982 [TBL] [Abstract][Full Text] [Related]
12. Multiple-dose pharmacokinetics of piperacillin and azlocillin in 12 healthy volunteers. Tartaglione TA; Nye L; Vishniavsky N; Poynor W; Polk RE Clin Pharm; 1986 Nov; 5(11):911-6. PubMed ID: 3780161 [TBL] [Abstract][Full Text] [Related]
13. Population Pharmacokinetics and Pharmacodynamics of Extended-Infusion Piperacillin and Tazobactam in Critically Ill Children. Nichols K; Chung EK; Knoderer CA; Buenger LE; Healy DP; Dees J; Crumby AS; Kays MB Antimicrob Agents Chemother; 2016 Jan; 60(1):522-31. PubMed ID: 26552978 [TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics of piperacillin in patients on peritoneal dialysis with and without peritonitis. Debruyne D; Ryckelynck JP; Hurault De Ligny B; Moulin M J Pharm Sci; 1990 Feb; 79(2):99-102. PubMed ID: 2324971 [TBL] [Abstract][Full Text] [Related]
15. The effect of hemodialysis on piperacillin pharmacokinetics. Heim-Duthoy KL; Halstenson CE; Abraham PA; Matzke GR Int J Clin Pharmacol Ther Toxicol; 1986 Dec; 24(12):680-4. PubMed ID: 3818147 [TBL] [Abstract][Full Text] [Related]
16. [Biliary elimination and hepatic disposition of piperacillin: experimental evaluation]. Brogard JM; Dorner M; Blickle JF; Jehl F; Monteil H Pathol Biol (Paris); 1990 Jun; 38(5 ( Pt 2)):495-9. PubMed ID: 2385445 [TBL] [Abstract][Full Text] [Related]
17. Clinical pharmacokinetics in patients with burns. Jaehde U; Sörgel F Clin Pharmacokinet; 1995 Jul; 29(1):15-28. PubMed ID: 7586895 [TBL] [Abstract][Full Text] [Related]